Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer-Reference-Cited by-同舟云学术

Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer

Published:1990 Issue:S1 Volume:26 Page:S63-S65
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother. Pharmacol.

Author:

Paridaens R.,Focan C.,Michel J.,Piccart M.,Salamon E.,Beauduin M.,Closon M. T.,Tueni E.,Vindevoghel A.,Majois F.,T'Hooft-Andry M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/BF00685423.pdf

Reference7 articles.

1. Andriole GL, Sandlung J, Miser J, Arasi V, Linehan M, Magrath I (1987) The efficacy of mesna (2-mercaptoethane sodium sulfonate) as a uroprotectant in patients with hemorrhagic cystitis receiving further oxazaphosphorine chemotherapy. J Clin Oncol 5: 799

2. Brade WP, Herdrich K, Varini M (1985) Ifosfamide?pharmacology, safety and therapeutic potential. Cancer Treat Rev 12: 1

3. Bramwell V, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verwey J, Dombernowsky P, Onsrud M, Thomas D, Sylvester R, Van Oosterom AT (EORTC Soft-tissue and Bone Sarcoma Group) (1987) Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft-tissue sarcomas. Eur J Cancer Clin Oncol 23: 311

4. Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response in advanced breast cancer. Eur J Cancer 13: 89

5. Loehrer PJ (ed) (1989) Current developments and future direction with ifosfamide. Semin Oncol 16 (1) [Suppl 3]

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of mesna to prevent ifosfamide-induced urotoxicity;Supportive Care in Cancer;1998-02

2. Phase II Clinical Trial of Carboplatin, Ifosfamide, with Oral Mesna for Metastatic Breast Carcinoma;Cancer Investigation;1995-01

3. Salvage therapies in women who fail to respond to first-line treatment with fluorouracil, epirubicin, and cyclophosphamide for advanced breast cancer.;Journal of Clinical Oncology;1994-08

4. Ifosfamide, mesna, and nephrotoxicity in children.;Journal of Clinical Oncology;1993-01

5. Use of ifosfamide in the management of breast cancer;Annals of Oncology;1992-08